Home » Authors » Mark Lawson

Articles by Mark Lawson

Peptech Suffers On Uncertainty Of Royalties For TNF Product

Feb. 26, 2003

SIRTeX Officials Welcome Idea Of $161M Acquisition By Cephalon

Feb. 19, 2003

SIRTeX Officials Welcome Idea Of $161M Acquisition By Cephalon

Feb. 19, 2003

Australian Stock Gains Could Signal A Turnaround In Sector

Jan. 29, 2003

Australian Stock Gains Could Signal A Turnaround In Sector

Jan. 29, 2003

Peptech Raises A$10M, Gets Boost By Approval Of Humira

Jan. 15, 2003

Peptech Raises A$10M, Gets Boost By Approval Of Humira

Jan. 15, 2003

BresaGen Licenses Patent Rights Related To Stem Cell Programs

Nov. 27, 2002

BresaGen Licenses Patent Rights Related To Stem Cell Programs

Nov. 27, 2002

Peptech Stock Declines Following News of Centocor Royalty Dispute

Nov. 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 26, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 26, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.